ArticleTherapeutic advances in neurological disorders2026

Real-world implementation of continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: first clinical experience from the Middle East.

Shivam Om Mittal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.